Mindray Medical International Stock Hits New 52-Week High (MR)

NEW YORK ( TheStreet) -- Mindray Medical International (NYSE: MR) hit a new 52-week high Tuesday as it is currently trading at $32.32, above its previous 52-week high of $32.29 with 260,163 shares traded as of 2:20 p.m. ET. Average volume has been 482,800 shares over the past 30 days.

Mindray Medical International has a market cap of $3.43 billion and is part of the health care sector and health services industry. Shares are up 24.1% year to date as of the close of trading on Monday.

Mindray Medical International Limited, through its subsidiary, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., develops, manufactures, and markets medical devices worldwide. The company has a P/E ratio of 20.1, below the average health services industry P/E ratio of 22.1 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Mindray Medical International as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, growth in earnings per share and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full Mindray Medical International Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

NYSE Trader Expects Blowout Earnings From Alphabet, Amazon and Facebook

NYSE Trader Expects Blowout Earnings From Alphabet, Amazon and Facebook

Don't Panic! The Risk of a Recession This Year Is Low

Don't Panic! The Risk of a Recession This Year Is Low

Even Standing Desk Company Varidesk Is Watching How the Trump Tariffs Play Out

Even Standing Desk Company Varidesk Is Watching How the Trump Tariffs Play Out

State Street Gets Pummeled on Software Deal; Pizza Wars Are Raging -- ICYMI

State Street Gets Pummeled on Software Deal; Pizza Wars Are Raging -- ICYMI

Schlumberger Stock Dips as Investors Ignore Start of 'Earnings Liftoff'

Schlumberger Stock Dips as Investors Ignore Start of 'Earnings Liftoff'